MC4R (Melanocortin-4 receptor)

MC4R (Melanocortin-4 receptor) is a Gs-coupled class A GPCR expressed at high density in hypothalamic nuclei — particularly the paraventricular nucleus — and throughout the brainstem and spinal cord. It is the primary receptor through which alpha-MSH and related melanocortin peptides regulate energy homeostasis, sexual function, autonomic nervous system activity, and cardiovascular tone.

Why it matters in peptide research

MC4R holds a unique position in peptide research because it links two seemingly disparate domains: metabolic regulation and sexual function. Its role in energy balance is well established — MC4R mutations are the most common monogenic cause of human obesity, and the receptor mediates anorexigenic signals from the arcuate nucleus's POMC neurons that suppress appetite and increase energy expenditure. Pharmaceutical targeting of MC4R for obesity has been challenging due to on-target cardiovascular and pro-erectile side effects.

Those same pro-sexual side effects became the therapeutic target for a distinct research and clinical application. The central localization of MC4R in circuits governing sexual motivation and arousal makes it a compelling target for treating sexual dysfunction. Activation of MC4R in the medial preoptic area and paraventricular nucleus initiates the neurochemical cascade that facilitates erection in males and engorgement and lubrication responses in females through a largely dopamine-independent, centrally-originating mechanism.

This central mechanism distinguishes MC4R agonism from PDE5 inhibitors (sildenafil, tadalafil), which act peripherally on vascular smooth muscle. MC4R agonists instead address the motivational and arousal components of sexual response — making them potentially effective where PDE5 inhibitors fail, such as in cases with a significant psychogenic or hormonal component.

Peptides that act on this

• PT-141 (Bremelanotide) — non-selective melanocortin receptor agonist with high affinity for MC4R and MC3R; FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women; widely studied in males for erectile and arousal effects.
• Melanotan II — non-selective melanocortin agonist with robust MC4R activity; historically used for tanning and sexual arousal research; not approved for human use.

Common misconceptions

MC4R agonists are sometimes categorized as "aphrodisiacs" — a term that implies enhancement of desire through a peripheral or non-specific stimulant mechanism. In reality, MC4R agonism is a centrally mediated, receptor-specific intervention that engages defined neural circuits for sexual arousal. Nausea is a common on-target side effect driven by MC4R activation in the area postrema; this can often be mitigated by dose titration and anti-nausea prophylaxis.